Dopamine D3 partial agonists in the treatment of psychosis and substance use disorder comorbidity, a pharmacological alternative to consider?
Dopamine D3 partial agonists in the treatment of psychosis and substance use disorder comorbidity, a pharmacological alternative to consider?
CNS Spectr. 2020 Jun 29;:1-6
Authors: Hernández-Huerta D, Morillo-González J
PMID: 32594931 [PubMed - as supplied by publisher]
Source: CNS Spectrums - Category: Neurology Authors: Hernández-Huerta D, Morillo-González J Tags: CNS Spectr Source Type: research
More News: Neurology